Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

SCM Pharma

SCM Pharma is a contract development & manufacturing organisation (CDMO) that develops and makes novel, difficult and dangerous drugs on behalf of our clients. Our formulation development, cGMP manufacturing and aseptic processing services include the sterile filling of liquids, gels and powders (including flammable products) into a range of final dosage forms including ampoules, vials, cartridges, syringes and bottles. So if you’re a pharmaceutical, biotech, medical device or healthcare institution in need of formulation development, clinical manufacturing or contract filling involving a complex product or process – let’s talk.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

SCM Pharma
Unit 6 Regents Drive, Low Prudhoe Industrial Estate, Prudhoe, Northumberland, NE42 6PX, United Kingdom
+44(0) 1661 833 693
Contact SCM Pharma
Website

 Latest Content from PMHub 

Thought Leaders in Medical Affairs: Key Trends & Challenges Shaping the Future of the Medical Affairs Role

Videos and Podcasts | October 7, 2022 | Medscape Medical Affairs

How can Medical Affairs divisions bring greater value to their organizations and practitioners every day?

Mobilizing Agitation Detection in Children with ADHD

Videos and Podcasts | October 7, 2022 | Impetus Digital

Marius Rus, founder of StressLess–the startup behind Tully–discusses wearable technologies for children with ADHD, autism, and other mental health conditions. He also shares his tips and lessons learned from founding...

Onyx Health Goes for International Growth with New Managing Director

Press Releases | October 6, 2022 | Onyx Health

Onyx Health has announced the appointment of Trevor Pill as their new Managing Director. He will be taking over the day-to-day running of the agency from owner and founder Karen...

Lifting the fog to help Clinical Labs navigate IVDR 2022

White Papers and Resources | October 6, 2022 | Create Health

In Vitro Diagnostic Regulation (IVDR 2022) was on the horizon: a new regulatory basis for laboratories to adhere to regarding their diagnostic equipment and tests.  BD wanted to let their customers...

Empowering adolescents to manage emotional and mental health issues

White Papers and Resources | October 6, 2022 | Create Health

1 in 10 UK children suffer with a mental health issue and alarmingly as many as 70% of these don’t receive the proper support they need. That’s why The Anna...

Reframing rare to increase earlier diagnosis of Gaucher Disease

White Papers and Resources | October 6, 2022 | Create Health

Sanofi Genzyme wanted to reach haematologists; the specialist physicians most likely to encounter patients with Gaucher Disease prior to diagnosis. The problem? Gaucher Disease is considered very rare and its...

Proving the power of a positive mindset to help fix all ills

White Papers and Resources | October 6, 2022 | Create Health

There’s a huge amount of fear around health conditions and disease – in fact according to Harvard Medical School, health anxiety affects 12% of adults. We wanted to put a...

Creating a monster to distrupt the market and solve a chronic problem

White Papers and Resources | October 6, 2022 | Create Health

ConvaTec launched AQUACEL Ag+ in 2014, a new class of dressing proven to disrupt and destroy biofilm. They came to us to help them position AQUACEL Ag+ as the solution...

Inspiring researchers to find the impossible with a next generation solution

White Papers and Resources | October 6, 2022 | Create Health

Though BD is very well known within the immunology and flowcytometry space, there is low awareness that BD is the only brand with a true multiomics offering. BD wanted to...

Keeping the food industry safe with next level protection solutions

White Papers and Resources | October 6, 2022 | Create Health

Thermo Fisher Scientific came to us when they needed to communicate their New Generation food production technologies.